Rapport Therapeutics raises over $400 million in capital offerings

Rapport Therapeutics raised over $400 million in capital offerings on October 30, 2026, including a public offering of common stock and pre-funded warrants, $172.5 million in 2.25% convertible senior notes due 2032, and a $30 million private placement. The offerings were underwritten by Morgan Stanley, Leerink Partners, and Evercore.

Detected & updated continuously · Source: Nebula